Literature DB >> 21210286

Relation of risk factors and putative premotor markers for Parkinson's disease.

I Liepelt-Scarfone1, S Behnke, J Godau, K J Schweitzer, B Wolf, A Gaenslen, D Berg.   

Abstract

As both risk and premotor markers are increasingly discussed to play a key role in the pre-diagnostic phase of Parkinson's disease (PD) the aim of this study was to determine the relation between the risk factors hyperechogenicity of the substantia nigra (SN+) and/or positive family history of PD (faPD+) and putative premotor markers for PD. In a cross-sectional analysis of data of the PRIPS cohort, 1,149 volunteers older than 50 years free of PD were included. In addition to the risk factors SN+ and faPD+, olfactory dysfunction was tested using the Sniffin' sticks test and motor examination was performed. History of depression and constipation was evaluated by a semi-structured interview. Of all 1,149 individuals, 880 had none of the risk markers (76.6%), 143 persons (12.4%) had SN+, 84 (7.3%) were classified as faPD+ and 42 (3.7%) persons had both risk factors. Volunteers with SN+ showed olfactory dysfunction and mild motor impairment (p ≤ 0.001) more often. Depression was more prominent in individuals having two risk factors (p = 0.05). An accumulation of premotor markers was seen in the SN+ group with or without concomitant faPD+, but not in persons with faPD+ only. The profile of premotor markers seems to differ in participants having SN+ and/or faPD+, with SN+ showing the overall highest association with most premotor markers, which implies that SN+ might be a strong indicator for a neurodegenerative process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210286     DOI: 10.1007/s00702-010-0553-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  33 in total

Review 1.  Transcranial brain parenchyma sonography in movement disorders: state of the art.

Authors:  Uwe Walter; Stefanie Behnke; Jens Eyding; Ludwig Niehaus; Thomas Postert; Günter Seidel; Daniela Berg
Journal:  Ultrasound Med Biol       Date:  2007-01       Impact factor: 2.998

2.  Brain parenchyma sonography detects preclinical parkinsonism.

Authors:  Uwe Walter; Christine Klein; Ruediger Hilker; Reiner Benecke; Peter P Pramstaller; Dirk Dressler
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

3.  Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.

Authors:  Daniela Berg; Klaus Seppi; Inga Liepelt; Katherine Schweitzer; Frank Wollenweber; Björn Wolf; Ulrich Dillmann; Heike Stockner; Jana Godau; Stefan Kiechl; Alexandra Gaenslen; Johann Willeit; Adriana Di Santo; Walter Maetzler; Thomas Gasser; Werner Poewe; Stefanie Behnke
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

4.  Relationship of substantia nigra echogenicity and motor function in elderly subjects.

Authors:  D Berg; C Siefker; P Ruprecht-Dörfler; G Becker
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Subjective complaints precede Parkinson disease: the rotterdam study.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Arch Neurol       Date:  2006-01-09

7.  Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Authors:  Uwe Walter; Jacqueline Hoeppner; Lara Prudente-Morrissey; Sebastian Horowski; Sabine C Herpertz; Reiner Benecke
Journal:  Brain       Date:  2007-02-28       Impact factor: 13.501

8.  Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group.

Authors:  A Elbaz; F Grigoletto; M Baldereschi; M M Breteler; J M Manubens-Bertran; S Lopez-Pousa; J F Dartigues; A Alpérovitch; C Tzourio; W A Rocca
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

9.  Familial Parkinson's disease: a community-based study.

Authors:  M Kurz; G Alves; D Aarsland; J P Larsen
Journal:  Eur J Neurol       Date:  2003-03       Impact factor: 6.089

10.  Use of antidepressants and the risk of Parkinson's disease: a prospective study.

Authors:  A Alonso; L A García Rodríguez; G Logroscino; M A Hernán
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06       Impact factor: 10.154

View more
  9 in total

Review 1.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

2.  Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.

Authors:  Danúbia Bonfanti Santos; Dirleise Colle; Eduardo Luiz Gasnhar Moreira; Mariana Appel Hort; Marcelo Godoi; Gael Le Douaron; Antonio Luiz Braga; Jamil Assreuy; Patrick Pierre Michel; Rui Daniel Prediger; Rita Raisman-Vozari; Marcelo Farina
Journal:  Mol Neurobiol       Date:  2016-02-06       Impact factor: 5.590

3.  α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.

Authors:  Joong-Seok Kim; In-Seok Park; Hyung-Eun Park; Su-Young Kim; Jung A Yun; Chan Kwon Jung; Hye-Young Sung; Jin-Kwon Lee; Won-Kyung Kang
Journal:  Neurol Sci       Date:  2016-11-01       Impact factor: 3.307

4.  Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Authors:  Uwe Walter; Robert Heilmann; Lara Kaulitz; Tino Just; Bernd Joachim Krause; Reiner Benecke; Jacqueline Höppner
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

Review 5.  Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice.

Authors:  Agata Aniszewska; Joakim Bergström; Martin Ingelsson; Sara Ekmark-Lewén
Journal:  Brain Behav       Date:  2022-06-01       Impact factor: 3.405

6.  Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study.

Authors:  Naveed Malek; Michael A Lawton; Katherine A Grosset; Nin Bajaj; Roger A Barker; David J Burn; Tom Foltynie; John Hardy; Huw R Morris; Nigel M Williams; Yoav Ben-Shlomo; Nicholas W Wood; Donald G Grosset
Journal:  Mov Disord Clin Pract       Date:  2016-11-24

7.  Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.

Authors:  Michelle Beavan; Alisdair McNeill; Christos Proukakis; Derralynn A Hughes; Atul Mehta; Anthony H V Schapira
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

Review 8.  Diagnostic biomarkers for Parkinson's disease at a glance: where are we?

Authors:  Ilaria Cova; Alberto Priori
Journal:  J Neural Transm (Vienna)       Date:  2018-08-25       Impact factor: 3.575

9.  Depressive disorders in the elderly and dementia: An update.

Authors:  Natália S Dias; Izabela G Barbosa; Weihong Kuang; Antonio L Teixeira
Journal:  Dement Neuropsychol       Date:  2020 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.